Body mass index and outcomes in breast cancer treated with breast conservation.
Obesity is increasing in incidence in New Zealand. Maintaining loco-regional control following breast cancer surgery is important as this can improve overall survival. While obesity has been associated with poorer survival in breast cancer, the correlation with locoregional control is less well evaluated and was the subject of this evaluation. We utilised the New Zealand breast cancer registry to identify patients treated with breast conservation with BMI recorded. We retrieved patient demographic, tumour characteristic and treatment related information. We assessed local, and locoregional control outcomes as well as breast cancer and overall survival outcomes. 2513 patients were identified. The median follow up was 5.25 years. 38% of patients were obese with a body mass index (BMI) of >30kg/m2, 32% were overweight with a BMI of 25.0-29.9kg/m2 and 29% were either normal or underweight with a BMI of <24.9kg/m2. Most patients were post-menopausal (65%). The median tumour size was 16.0mm (0.2mm - 80mm) and the majority were grade 2 or 3 tumours (45% and 33%). The majority (66%) were pathologically node negative and LVI was seen in 24%. There were 81% with ER positivity and 358 (14.2%) were Her-2 positive. Local relapse free survival at 5 years was 91.5% (95% CI 90.3-92.7) and at 10 years was 78.5% (95% CI 75.9-81.1). Local relapse free rate at 5 years was 96.8% (95% CI 96.0-97.6) and 10 years was 93.9% (95% CI 92.5-95.3). We did not find BMI to be associated with local or locoregional relapse, disease free, breast cancer specific or overall survival. Obesity was not associated with inferior locoregional control or survival outcomes. This supports the practice of continuing to offer breast conserving treatment to women regardless of BMI.